Recombinant Anti-CD52 (Clone Campath-1H)
Applications | CT, ELISA, FC, IHC, WB |
Reactivities | Human, Monkey |
Recombinant Anti-CD52 (Clone Campath-1H)
Applications | CT, ELISA, FC, IHC, WB |
Reactivities | Human, Monkey |
Recombinant Anti-EGFR (Clone Matuzumab)
Applications | Bl, ELISA, FC, IF, WB |
Reactivities | Human |
Recombinant Anti-TRP-1, gp75 (Clone TA99)
Applications | ELISA, FC, IF, IHC, IP, WB |
Reactivities | Human |
Recombinant Anti-TNF alpha (Clone cA2 (Infliximab))
Applications | ELISA, FC |
Reactivities | Human |
Recombinant Anti-VEGF (Clone Bevacizumab)
Applications | Bl, ELISA, FC, IP, WB |
Reactivities | Human |
Recombinant Anti-Human Ephrin Type A receptor 2 (Clone 1C1)
Applications | ELISA, FC, IF, WB |
Reactivities | Human |
Recombinant Anti-TNF alpha (Clone D2E7 (Adalimumab))
Applications | Bl, ELISA, IF, IHC |
Reactivities | Human |
Anti-Laminin-2 LG5 [C3_Hu10], Human IgG1, kappa
Applications | ELISA, FC, IF, WB |
Reactivities | Human, Mouse |
Recombinant Anti-erbB-2 (Her-2/neu) (Clone 4D5-8 (trastuzumab))
Applications | ELISA, FC, IHC |
Reactivities | Human |
Recombinant Anti-Covid-19 & SARS-CoV Nucleoprotein (Clone CR3018 (03-018))
Applications | ELISA, IF |
Reactivities | SARS-CoV |
Recombinant Anti-EGFR (Clone 2F8 (Zalutumumab; HuMax-EGFR))
Applications | ELISA, FC, WB |
Reactivities | Human |
Recombinant Anti-ED-B domain of fibronectin (Clone A2)
Applications | ELISA, IHC, WB |
Reactivities | Human |
Recombinant Anti-ED-B domain of fibronectin (Clone G4)
Applications | ELISA, IHC, WB |
Reactivities | Human |
Anti-IL-8 [WS-4], Human IgG1, kappa
Applications | ELISA, IHC, Neutralize |
Reactivities | Human, Rabbit |
Recombinant Anti-Covid-19 & SARS-CoV Nucleoprotein (Clone CR3009 (03-009))
Applications | ELISA, IF |
Reactivities | SARS-CoV |